Abstract:Supplemental Digital Content is available in the text. Rationale: Specific mechanisms linking inflammation and metabolic reprogramming—two hallmarks of many pathobiological processes—remain incompletely defined. Objective: To delineate the integrative regulatory actions governing inflammation and metabolism in endothelial cells. Methods and Results: Metabolomic profiling, glucose labeling and tracing, and Seahorse extracellular flux analyses revealed that the inflammatory mediators, TNFα (tumor necrosis factor alpha) and lipopolysaccharide, extensively reprogram cellular metabolism and particularly enhance glycolysis, mitochondrial oxidative phosphorylation (OXPHOS), and the pentose phosphate pathway in primary human arterial endothelial cells. Mechanistically, the enhancement in glycolysis and pentose phosphate pathway is mediated by activation of the NF-κB (nuclear factor-kappa B)–PFKFB3 (6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase 3) axis and upregulation of G6PD (glucose 6-phosphate dehydrogenase), respectively, while enhanced OXPHOS was attributed to suppression of the FOXO1 (forkhead box O1)-PDK4 (pyruvate dehydrogenase kinase 4) axis. Restoration of the FOXO1-PDK4 axis attenuated the TNFα- or lipopolysaccharide-induced increase in OXPHOS but worsened inflammation in vitro, whereas enhancement of OXPHOS by pharmacological blockade of PDKs attenuated inflammation in mesenteric vessels of lipopolysaccharide-treated mice. Notably, suppression of G6PD expression or its activity potentiated the metabolic shift to glycolysis or endothelial inflammation, while inhibition of the NF-κB–PFKFB3 signaling, conversely, blunted the increased glycolysis or inflammation in in vitro and in vivo sepsis models. Conclusions: These results indicate that inflammatory mediators modulate the metabolic fates of glucose and that stimulation of glycolysis promotes inflammation, whereas enhancement of OXPHOS and the pentose phosphate pathway suppresses inflammation in the endothelium. Characterization of these immunometabolic phenotypes may have implications for the pathogenesis and treatment of many cardiovascular diseases.

[Energy metabolism of the immune system : Consequences in chronic inflammation]

Cellular energy metabolism in T-lymphocytes

Metabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation

The brain and immune system prompt energy shortage in chronic inflammation and ageing

The interplay between inflammation and metabolism in rheumatoid arthritis

Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis

The human body as an energetic hybrid? New perspectives for chronic disease treatment?

Metabolic Reprogramming in Immune Response and Tissue Inflammation

The bioenergetics of inflammation: insights into obesity and type 2 diabetes

Metabolic Signatures of T-cells and Macrophages in Rheumatoid Arthritis.

Deciphering metabolic crosstalk in context: lessons from inflammatory diseases

Postprandial Dysmetabolism and Its Medical Implications

Rheumatic diseases and metabolism: where centre and periphery meet

Chronic Effects of the Sympathetic Nervous System in Inflammatory Models

Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications

Similarities in the Metabolic Reprogramming of Immune System and Endothelium

Regulation of Energy Balance by Inflammation: Common Theme in Physiology and Pathology

Immunometabolic Endothelial Phenotypes

Fatty acid oxidation in immune function

Frontline Science: Monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response

The inflammation highway: metabolism accelerates inflammatory traffic in obesity